Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($0.99), $0.51 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $696.22 million versus the consensus estimate of $696.22 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.